Jamie Westenberg / Android Authority
- Garmin has announced a new clinically tested ECG app with FDA approval.
- The app will be available on the Garmin Venu 2 Plus for users in the US.
- With real-time ECG recording capabilities, the app will help users check for signs of atrial fibrillation (aFib).
Garmin goes after the hearts of users with a new clinically validated ECG app that today reaches the top of the brand smart watch. The FDA-approved gadget aims to help users closely monitor their health, using sensors on their devices. Garmin Venue 2 Plus To record the electrical signals from the users’ hearts.
ECG capabilities aren’t new to consumer wearables; However, approval of these tools is not always easy. The arrival of a validated application into the Garmin ecosystem is a major addition to an already robust platform. Eligible users can immediately access the app to record on-demand ECG readings directly on the wrist. After thirty seconds, the application will display the results of the heartbeat.
Most importantly, the app analyzes users’ scores for health concerns such as early signs of AFib. If synced with Garmin Connect, the app will also provide users with a history of their ECG app recordings. It can then be shared with medical professionals from a smartphone app.
For now, the Kansas-based company has announced that the ECG app is only available to users in the United States. Also accessible on Venu 2 Plus only. Going forward, Garmin plans to continue expanding the launch to additional products. Furthermore, the app will be made available to more users as the company meets necessary regulatory approval in additional regions. Make sure your device is using the latest version Garmin Connect Access the ECG app on your Venu 2 Plus now.